Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Prevalence and prevention of cardiovascular disease and diabetes mellitus.

Balakumar P, Maung-U K, Jagadeesh G.

Pharmacol Res. 2016 Nov;113(Pt A):600-609. doi: 10.1016/j.phrs.2016.09.040. Review.

PMID:
27697647
2.

Effect of edaravone in diabetes mellitus-induced nephropathy in rats.

Varatharajan R, Lim LX, Tan K, Tay CS, Teoh YL, Akhtar SS, Rupeshkumar M, Chung I, Abdullah NA, Banik U, Dhanaraj SA, Balakumar P.

Korean J Physiol Pharmacol. 2016 Jul;20(4):333-40. doi: 10.4196/kjpp.2016.20.4.333.

3.

Chronic oral administration of low-dose combination of fenofibrate and rosuvastatin protects the rat heart against experimentally induced acute myocardial infarction.

Garg M, Khanna D, Kalra S, Balakumar P.

Fundam Clin Pharmacol. 2016 Oct;30(5):394-405. doi: 10.1111/fcp.12204.

PMID:
27148865
4.

Cardiovascular drugs-induced oral toxicities: A murky area to be revisited and illuminated.

Balakumar P, Kavitha M, Nanditha S.

Pharmacol Res. 2015 Dec;102:81-9. doi: 10.1016/j.phrs.2015.09.007. Review.

PMID:
26409645
5.

Implications of fundamental signalling alterations in diabetes mellitus-associated cardiovascular disease .

Balakumar P.

Indian J Biochem Biophys. 2014 Dec;51(6):441-8. Review.

PMID:
25823215
6.

A step ahead of PPARγ full agonists to PPARγ partial agonists: therapeutic perspectives in the management of diabetic insulin resistance.

Chigurupati S, Dhanaraj SA, Balakumar P.

Eur J Pharmacol. 2015 May 15;755:50-7. doi: 10.1016/j.ejphar.2015.02.043. Review.

PMID:
25748601
7.

Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.

Balakumar P, Varatharajan R, Nyo YH, Renushia R, Raaginey D, Oh AN, Akhtar SS, Rupeshkumar M, Sundram K, Dhanaraj SA.

Pharmacol Res. 2014 Dec;90:36-47. doi: 10.1016/j.phrs.2014.08.008.

PMID:
25263930
8.

Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor.

Balakumar P, Jagadeesh G.

J Mol Endocrinol. 2014 Oct;53(2):R71-92. doi: 10.1530/JME-14-0125. Review.

9.

A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.

Balakumar P, Jagadeesh G.

Cell Signal. 2014 Oct;26(10):2147-60. doi: 10.1016/j.cellsig.2014.06.011. Review.

PMID:
25007996
10.

Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel?

Balakumar P, Nyo YH, Renushia R, Raaginey D, Oh AN, Varatharajan R, Dhanaraj SA.

Pharmacol Res. 2014 Sep;87:144-50. doi: 10.1016/j.phrs.2014.05.008. Review.

PMID:
24861566
11.

Nephroprotective effect of catechin on gentamicin-induced experimental nephrotoxicity.

Sardana A, Kalra S, Khanna D, Balakumar P.

Clin Exp Nephrol. 2015 Apr;19(2):178-84. doi: 10.1007/s10157-014-0980-3.

PMID:
24825545
12.

Dapagliflozin: glucuretic action and beyond.

Balakumar P, Sundram K, Dhanaraj SA.

Pharmacol Res. 2014 Apr;82:34-9. doi: 10.1016/j.phrs.2014.03.008. Review.

PMID:
24705156
13.

Low-dose dipyridamole treatment partially prevents diabetes mellitus-induced vascular endothelial and renal abnormalities in rats.

Sharma AK, Khanna D, Balakumar P.

Int J Cardiol. 2014 Mar 15;172(2):530-2. doi: 10.1016/j.ijcard.2014.01.053. No abstract available.

PMID:
24495652
14.

Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.

Bhardwaj P, Khanna D, Balakumar P.

Cardiovasc Toxicol. 2014 Mar;14(1):41-51. doi: 10.1007/s12012-013-9226-y.

PMID:
24048981
16.

Cardiovascular pleiotropic actions of DPP-4 inhibitors: a step at the cutting edge in understanding their additional therapeutic potentials.

Balakumar P, Dhanaraj SA.

Cell Signal. 2013 Sep;25(9):1799-803. doi: 10.1016/j.cellsig.2013.05.009. Review.

PMID:
23707531
17.

Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heart.

Babbar L, Mahadevan N, Balakumar P.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386(4):319-29. doi: 10.1007/s00210-012-0830-3.

PMID:
23325365
18.

Biomedical research - from ideation to publication.

Balakumar P.

J Nat Sci Biol Med. 2012 Jul;3(2):212. doi: 10.4103/0976-9668.101938. No abstract available.

19.

Fish oil blunted nicotine-induced vascular endothelial abnormalities possibly via activation of PPARγ-eNOS-NO signals.

Taneja G, Mahadevan N, Balakumar P.

Cardiovasc Toxicol. 2013 Jun;13(2):110-22. doi: 10.1007/s12012-012-9190-y.

PMID:
23208382
20.

Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.

Kathuria S, Mahadevan N, Balakumar P.

Mol Cell Biochem. 2013 Feb;374(1-2):61-72. doi: 10.1007/s11010-012-1505-6.

PMID:
23149826
Items per page

Supplemental Content

Loading ...
Support Center